MedTrace Logo

Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP

NCT06382974 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-08-13

No results posted yet for this study

Summary

This case series study aims to evaluate the local effects of Atorvastatin (which belongs to the family of lipid-lowering drugs, known as statins) combined with β-TCP (which is a synthetic osteoconductive bone graft), on the volume of the residual bone defects and on hastening the bone regeneration after radicular jaw cyst enucleation using CBCT-based volumetric analysis to calculate the shrinkage rate of these defects.

Conditions

Interventions

PROCEDURE

Cyst enucleation and bone grafting

cyst enucleation followed by bone grafting the residual bone defects using Atorvastatin combined with β-TCP.

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Salah Yassin · department of oral and maxillofacial surgery, cairo university

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-31
Primary Completion
2025-12-31
Completion
2026-03-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06382974 on ClinicalTrials.gov